ClinicalTrials.Veeva

Menu

CCTA-based Coronary Plaque Characterization and High-sensitive Troponin T for the Prediction of Cardiovascular Outcomes

U

University Hospital Heidelberg

Status

Completed

Conditions

Coronary Artery Disease
Noninvasive Plaque Characterization

Study type

Observational

Funder types

Other

Identifiers

NCT02030704
HDCCTA01

Details and patient eligibility

About

To determine the ability of semi-automated plaque assessment in cardiac computed tomography angiography (CCTA) and high sensitive troponin T (hsTnT) for the risk stratification of patients at intermediate risk for coronary artery disease (CAD).

Enrollment

300 patients

Sex

All

Ages

18 to 90 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Clinical indication for CCTA according to the current appropriate use criteria

Exclusion criteria

  • non-sinus rhythm
  • acute coronary syndromes
  • cardiomyopathies
  • moderate or severe valvular disease
  • elevated serum creatinine (>1.5 mg/dl)
  • history or ECG signs of previous myocardial infarction
  • severe iodine allergy.

Trial design

300 participants in 1 patient group

Atherosclerotic Plaque

Trial contacts and locations

2

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems